切换导航
  • 比较产品
我的购物车

若您需要咨询产品或有任何技术问题，请通过官方电话 400 885 9050 或邮箱 info.cn@stemcell.com 与我们联系

MegaCult™-C cfu染色试剂盒

人CFU-Mk染色试剂盒
率先评论此产品
添加并比较

产品号 #（选择产品）

产品号 #04962_C

人CFU-Mk染色试剂盒

产品组分包括

  • MegaCult™-C一抗，360µL（产品编号04803）
  • MegaCult™-C Control Antibody, 100µL（产品编号04804）
  • MegaCult™-C人血清，6 mL（目录#04807）
  • MegaCult™-C碱性磷酸酶底物片，1包（目录#04809）
  • MegaCult™-C亲和素碱性磷酸酶偶联物，200µL（目录#04905）
  • MegaCult™-C生物素偶联山羊抗小鼠IgG， 125µL（目录#04906）
  • MegaCult™-C Evans蓝色染色剂，5 mL（目录#04913）
  • MegaCult™- 10% BSA, 6 mL（目录#04915）
main product photo
总览
实验数据
产品说明书及文档
应用领域
相关材料与文献
相关产品

总览

使用MegaCult™-C CFU-Mk染色试剂盒中包含的试剂对MegaCult™-C胶原基培养基中培养的固定和脱水CFU-Mk菌落进行染色。
•MegaCult™-C一抗
•MegaCult™-C Control Antibody
MegaCult™-C人血清
•MegaCult™-C碱性磷酸酶底物片
MegaCult™-C生物素偶联山羊抗小鼠IgG
•MegaCult™-埃文斯蓝染色剂
MegaCult™- 10% BSA

用抗人CD41抗体和碱性磷酸酶检测系统对表达糖蛋白IIb/IIIa的巨核细胞和血小板进行染色。该试剂盒也适用于双电位红细胞巨核细胞祖细胞（BFU-E/Mk）的检测。

为了您的方便，工具包组件也可单独购买，根据要求。

Cell Type
Hematopoietic Stem and Progenitor Cells
 
Species
Human
 
Application
Colony Assay, Immunocytochemistry
 
Brand
MegaCult
 
Area of Interest
Stem Cell Biology
 

查看更多 显示更少

实验数据

Examples of colonies derived from human megakaryocyte progenitors

Figure 1. Examples of Colonies Derived from Human Megakaryocyte Progenitors

产品说明书及文档

请在《产品说明书》中查找相关支持信息和使用说明，或浏览下方更多实验方案。

Document Type
Product Name
Catalog #
Lot #
Language
Document Type
Product Information Sheet
Product Name
MegaCult™-C Staining Kit for CFU-Mk
Catalog #
04962
Lot #
All
Language
English
Document Type
Technical Manual
Product Name
MegaCult™-C Staining Kit for CFU-Mk
Catalog #
04962
Lot #
All
Language
English
Document Type
Safety Data Sheet 1
Product Name
MegaCult™-C Staining Kit for CFU-Mk
Catalog #
04962
Lot #
All
Language
English
Document Type
Safety Data Sheet 2
Product Name
MegaCult™-C Staining Kit for CFU-Mk
Catalog #
04962
Lot #
All
Language
English
Document Type
Safety Data Sheet 3
Product Name
MegaCult™-C Staining Kit for CFU-Mk
Catalog #
04962
Lot #
All
Language
English
Document Type
Safety Data Sheet 4
Product Name
MegaCult™-C Staining Kit for CFU-Mk
Catalog #
04962
Lot #
All
Language
English
Document Type
Safety Data Sheet 5
Product Name
MegaCult™-C Staining Kit for CFU-Mk
Catalog #
04962
Lot #
All
Language
English
Document Type
Safety Data Sheet 6
Product Name
MegaCult™-C Staining Kit for CFU-Mk
Catalog #
04962
Lot #
All
Language
English
Document Type
Safety Data Sheet 7
Product Name
MegaCult™-C Staining Kit for CFU-Mk
Catalog #
04962
Lot #
All
Language
English

应用领域

本产品专为以下研究领域设计，适用于工作流程中的高亮阶段。探索这些工作流程，了解更多我们为各研究领域提供的其他配套产品。

Research Area
Workflow Stages

相关材料与文献

技术资料 (2)

Hematopoietic Stem and Progenitor Cells - Products for Your Research
Brochure
Hematopoietic Stem and Progenitor Cells - Products for Your Research
Hematopoietic Stem and Progenitor Cells (HSPCs): Isolation, Culture, and Assays
Mini Review
Hematopoietic Stem and Progenitor Cells (HSPCs): Isolation, Culture, and Assays

常见问题

Why is the MegaCult™-C formulation serum free?

MegaCult™-C is formulated without FBS to avoid inhibition of CFU-Mk growth by TGF beta and Platelet Factor-4, which are often present in the serum.

Why use semi-solid media?

Semi-solid media (such as methylcellulose-based or collagen-based) allow the clonal progeny of a single progenitor cell to stay together so you can recognize distinct colonies.

文献 (5)

Comparison of four serum-free, cytokine-free media for analysis of endogenous erythroid colony growth in polycythemia vera and essential thrombocythemia. Dobo I et al. The hematology journal : the official journal of the European Haematology Association / EHA 2001 JAN

Abstract

INTRODUCTION: The assay of endogenous erythroid colony formation (EEC), a characteristic of polycythemia vera and essential thrombocythemia, is not standardized. In this multicentric study, we tested four semisolid, serum-free, cytokine-free media based on either methylcellulose (M1, M2) or collagen (C1, C2) commercialized for the EEC assay. MATERIALS AND METHODS: Bone marrow mononuclear cells (BMMC) from 73 individuals (62 patients with either polycythemia vera (26), essential thrombocythemia (19), secondary polyglobuly (17) or chronic myeloid leukemia (2) and 11 healthy donors) were grown in parallel in the four media without, or with 0.01 U/ml erythropoietin (EPo). RESULTS: In all four media EEC formation was specific, as it was not observed in cultures of patients with secondary polyglobuly or chronic myeloid leukemia, nor of healthy donors. Analysis of fresh or MGG-stained collagen gel cultures allowed detection of EEC formation significantly more frequently than methylcellulose-based media; addition of 0.01 U/ml of EPo had little or no effect on EEC formation. Collagen-based medium C1 gave better results than the other media tested: the 'C1' EEC assay was positive for 68.2% of polycythemia vera cultures with significantly higher median EEC numbers (6.5/10(5) BMMC for patients with one major criteria of polycythemia vera and 19 and 21/10(5) BMMC for patients with two or three major criteria, respectively). Medium C1 was also better for essential thrombocythemia cultures with 47.4% of positive results but with a low median EEC number (6.7/10(5) BMMC). When associated with the ELISA dosage of serum EPo, the 'C1' EEC assay allowed confirmation or elimination of the diagnosis of polycythemia vera for 91% (20/22) of polyglobulic patients. CONCLUSION: We propose that serum-free collagen-based culture systems be considered to standardize the EEC assay, now part of the new criteria of polycythemia vera.
View publication
Endogenous erythroid and megakaryocytic colony formation in serum-free, cytokine-free collagen gels. Dobo I et al. Journal of hematotherapy & stem cell research 1999 DEC

Abstract

We studied the suitability of collagen-based semisolid medium for assay of endogenous erythroid colony formation performed in myeloproliferative disorders. Bone marrow (BM) mononuclear cells (MNC) from 103 patients suspected of having polycythemia vera (PV, 76 patients) or essential thrombocythemia (ET, 27 patients) were grown in collagen-based, serum-free, cytokine-free semisolid medium. Colony analysis at day 8 or 10 showed that this collagen assay is specific, as endogenous growth of erythroid colonies was never observed in cultures of 16 healthy donors and 6 chronic myelogenous leukemia (CML) patients. Endogenous erythroid colony formation was observed in 53.3% of patients suspected of PV, with only 15.4% of positive cultures for patients with 1 minor PV criterion and 72% (p = 0.009) of positive cultures for patients with textgreater or =2 minor or 1 major PV criterion. Similarly, endogenous growth of erythroid colonies was found in 44.4% of patients suspected of ET, with 31.6% of positive cultures for patients with 1 ET criterion versus 75% for patients with textgreater or =2 ET criteria. In addition, we found that in collagen gels, tests of erythropoietin (EPO) hypersensitivity in the presence of 0.01 or 0.05 U/ml of EPO and tests of endogenous colony-forming units-megakaryocyte (CFU-MK) formation cannot be used to detect PV or ET, as these tests were positive for, respectively, 21.4% and 50% of healthy donors and 83% and 50% of CML patients. A retrospective analysis suggests that collagen assays are more sensitive than methylcellulose assays to assess endogenous growth of erythroid colonies. In summary, serum-free collagen-based colony assays are simple and reliable assays of endogenous growth of erythroid colonies in myeloproliferative diseases. They also appear to be more sensitive than methylcellulose-based assays.
View publication
Quantitation and characterization of human megakaryocyte colony-forming cells using a standardized serum-free agarose assay. Hogge D et al. British journal of haematology 1997 MAR

Abstract

Human progenitors of the megakaryocyte (Mk) lineage were detected by their ability to generate colonies-containing from 3 to textgreater 100 Mk, detectable as glycoprotein IIb/IIIa+ cells in APAAP-stained whole mount agarose cultures. Optimal growth conditions were achieved through the use of a defined serum substitute and a suitable cocktail of recombinant cytokines. Under these culture conditions, the smallest Mk-containing colonies (CFC-Mk) were detectable within a week followed by colonies containing larger numbers of Mk over the ensuing 2 weeks. The total number of CFC-Mk at 18-21 d was linearly related to the number of cells plated. Variation in the cytokines added showed that thrombopoietin (TPO) or IL-3 alone would support the formation of large numbers of CFC-Mk. However, optimal yields of colonies containing cells of both Mk and non-Mk lineages required the addition of other growth factors, of which a combination of IL-3, IL-6, GM-CSF and Steel factor (SF) +/- TPO was the best of those tested. The further addition of erythropoietin to this combination reduced the number of large pure' Mk colonies seen and in their place a corresponding number of mixed erythroid-Mk colonies became detectable. Flt3-ligand alone was unable to support the growth of CFC-Mk nor did it enhance their growth when combined with other factors. Plating of FACS-sorted sub-populations of CD34+ marrow cells in both serum-free agarose and methylcellulose assays demonstrated that most CFC-Mk are generated from CD34+ cells that are CD45RA- and CD71+�
View publication
View All Publications

更多信息

更多信息
种属 Human
质量保证:

产品仅供研究使用，不用于针对人或动物的诊断或治疗。
Copyright © 2025 by STEMCELL Technologies. All rights reserved.